Access to medicines - time for a progressive model Richard Bergström, EFPIA Director General 1 - Anti-diabetic drugs - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-04-12 03:23:25 Chemistry Liraglutide Exenatide Anti-diabetic medication European Federation of Pharmaceutical Industries and Associations Innovation Organisation for Economic Co-operation and Development Denmark Magnesium in biology Anti-diabetic drugs Europe Endocrine system		Access to medicines - time for a progressive model Richard Bergström, EFPIA Director General 1 Add to Reading List Source URL: www.efpia.eu Download Document from Source Website File Size: 1,99 MB Share Document on Facebook

	EMDAC Background document Victoza (liraglutide) - LEADER FDA Briefing Document Endocrinologic and Metabolic Drugs Advisory Committee Meeting (EMDAC) DocID: 1ts1R - View Document
	Victoza (liraglutide [rDNA origin] injection DocID: 1nE7h - View Document
	Access to medicines - time for a progressive model Richard Bergström, EFPIA Director General 1 DocID: 1aTpx - View Document
	PDF Document DocID: 16ope - View Document
	12933_2015_206_Article 1..11 DocID: 15UUB - View Document